Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1991 Apr;31(4):399–403. doi: 10.1111/j.1365-2125.1991.tb05552.x

Ethnic differences in the pharmacokinetics of oral nifedipine.

C H Ahsan 1, A G Renwick 1, B Macklin 1, V F Challenor 1, D G Waller 1, C F George 1
PMCID: PMC1368324  PMID: 2049247

Abstract

1. The pharmacokinetics of a single oral dose of 20 mg nifedipine, given as capsules, has been compared in five South Asian volunteers with data for 27 Caucasian volunteers. 2. The area under the plasma concentration-time curve (AUC) of nifedipine was three fold higher in South Asians (989 +/- 166 ng ml-1 h) than in Caucasians (323 +/- 116 ng ml-1 h). 3. The ratio of the AUC of nifedipine to that of the nitropyridine analogue, which is formed largely as a first pass metabolite, was significantly higher in South Asians (4.6 +/- 1.9) than in Caucasians (2.3 +/- 1.1) indicating a lower first pass metabolism in South Asians. 4. The terminal half-lives of nifedipine and the nitropyridine metabolite were significantly greater in South Asians than in Caucasians. 5. Consumption of a spicy curry diet for 3 days by Caucasians did not significantly affect the pharmacokinetics of a single oral dose of nifedipine. 6. The treatment of patients of South Asian origin with nifedipine should be initiated with lower doses than would be given to Caucasians.

Full text

PDF
399

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Challenor V. F., Waller D. G., Renwick A. G., Gruchy B. S., George C. F. The trans-hepatic extraction of nifedipine. Br J Clin Pharmacol. 1987 Oct;24(4):473–477. doi: 10.1111/j.1365-2125.1987.tb03200.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Foster T. S., Hamann S. R., Richards V. R., Bryant P. J., Graves D. A., McAllister R. G. Nifedipine kinetics and bioavailability after single intravenous and oral doses in normal subjects. J Clin Pharmacol. 1983 Apr;23(4):161–170. doi: 10.1002/j.1552-4604.1983.tb02720.x. [DOI] [PubMed] [Google Scholar]
  3. Guengerich F. P., Martin M. V., Beaune P. H., Kremers P., Wolff T., Waxman D. J. Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism. J Biol Chem. 1986 Apr 15;261(11):5051–5060. [PubMed] [Google Scholar]
  4. Guengerich F. P., Umbenhauer D. R., Churchill P. F., Beaune P. H., Böcker R., Knodell R. G., Martin M. V., Lloyd R. S. Polymorphism of human cytochrome P-450. Xenobiotica. 1987 Mar;17(3):311–316. doi: 10.3109/00498258709043941. [DOI] [PubMed] [Google Scholar]
  5. Horster F. A., Duhm B., Maul W., Medenwald H., Patzschke K., Wegner L. A. Klinische Untersuchungen zur Pharmakokinetik von radioaktiv markiertem 4-(2'-Nitrophenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsäuredimethylester. Arzneimittelforschung. 1972 Feb;22(2):330–334. [PubMed] [Google Scholar]
  6. Hoyo-Vadillo C., Castañeda-Hernández G., Herrera J. E., Vidal-Gárate J., Moreno-Ramos A., Chávez F., Hong E. Pharmacokinetics of nifedipine slow release tablet in Mexican subjects: further evidence for an oxidation polymorphism. J Clin Pharmacol. 1989 Sep;29(9):816–820. doi: 10.1002/j.1552-4604.1989.tb03425.x. [DOI] [PubMed] [Google Scholar]
  7. Kleinbloesem C. H., Van Harten J., Van Brummelen P., Breimer D. D. Liquid chromatographic determination of nifedipine in plasma and of its main metabolite in urine. J Chromatogr. 1984 Jun 8;308:209–216. doi: 10.1016/s0021-9673(01)87547-6. [DOI] [PubMed] [Google Scholar]
  8. Kleinbloesem C. H., van Brummelen P., Faber H., Danhof M., Vermeulen N. P., Breimer D. D. Variability in nifedipine pharmacokinetics and dynamics: a new oxidation polymorphism in man. Biochem Pharmacol. 1984 Nov 15;33(22):3721–3724. doi: 10.1016/0006-2952(84)90165-5. [DOI] [PubMed] [Google Scholar]
  9. Nebert D. W., Adesnik M., Coon M. J., Estabrook R. W., Gonzalez F. J., Guengerich F. P., Gunsalus I. C., Johnson E. F., Kemper B., Levin W. The P450 gene superfamily: recommended nomenclature. DNA. 1987 Feb;6(1):1–11. doi: 10.1089/dna.1987.6.1. [DOI] [PubMed] [Google Scholar]
  10. Otto J., Lesko L. J. Protein binding of nifedipine. J Pharm Pharmacol. 1986 May;38(5):399–400. doi: 10.1111/j.2042-7158.1986.tb04598.x. [DOI] [PubMed] [Google Scholar]
  11. Rahman M. A., Bennett T. The effects of propranolol or atenolol on the cardiovascular responses to central hypovolaemia in Europeans and Bengalees. Br J Clin Pharmacol. 1990 Jan;29(1):69–77. doi: 10.1111/j.1365-2125.1990.tb03604.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Renwick A. G., Le Vie J., Challenor V. F., Waller D. G., Gruchy B., George C. F. Factors affecting the pharmacokinetics of nifedipine. Eur J Clin Pharmacol. 1987;32(4):351–355. doi: 10.1007/BF00543968. [DOI] [PubMed] [Google Scholar]
  13. Renwick A. G., Robertson D. R., Macklin B., Challenor V., Waller D. G., George C. F. The pharmacokinetics of oral nifedipine--a population study. Br J Clin Pharmacol. 1988 Jun;25(6):701–708. doi: 10.1111/j.1365-2125.1988.tb05256.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Robertson D. R., Waller D. G., Renwick A. G., George C. F. Age-related changes in the pharmacokinetics and pharmacodynamics of nifedipine. Br J Clin Pharmacol. 1988 Mar;25(3):297–305. doi: 10.1111/j.1365-2125.1988.tb03307.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Schellens J. H., Soons P. A., Breimer D. D. Lack of bimodality in nifedipine plasma kinetics in a large population of healthy subjects. Biochem Pharmacol. 1988 Jul 1;37(13):2507–2510. doi: 10.1016/0006-2952(88)90238-9. [DOI] [PubMed] [Google Scholar]
  16. Waller D. G., Renwick A. G., Gruchy B. S., George C. F. The first pass metabolism of nifedipine in man. Br J Clin Pharmacol. 1984 Dec;18(6):951–954. doi: 10.1111/j.1365-2125.1984.tb02569.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES